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It is no secret that the link between infection and vasculitis is
well established even though the exact mechanism is still under
study [1]. Infection, in addition to other factors, has been counted to
trigger Vasculitis. The causal relationship has been documented
only in few cases like Polyarthritis Nodosa (PNA)/Hepatitis B virus
(HBV) and Cryoglobulinemia/Hepatitis C virus (HCV) cases [1].
There has also been an established link between Methicillin-
Resistant-Staphylococcus aureus (MRSA) and Microscopic Poly-
angitis with perinuclear anti-neutrophils-cytoplasmic-antibody (P-
ANCA) [2]. In addition, post MRSA infection IgA glomerulonephritis
[2] is well described.
We present a rare case of pulmonary-renal syndrome secondary
to recurrent MRSA spondylodiscitis. The mechanism of involve-
ment of each organ system is unique. The organs, lung and kidneys,
have been affected by different pathologic processes that were
induced, we think, by the chronic MRSA infection.
2. Case report
Our patient is 37-years-old white morbid obese female. She* Corresponding author.
E-mail address: drmmegri@gmail.com (M. Megri).
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2213-0071/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article uoriginally presented with MRSA spondylodiscitis at L3-L4 vertebral
level and bilateral Psoas muscle abscesses. She was treated for 6
weeks with IV antibiotics with apparent resolution of symptoms.
Two months after ﬁnishing her antibiotic regimen, the patient
presented with worsening lower back pain for one-week duration.
She has a previous history of IV drug abuse up until the episode of
the initial infection but denies any recent abuse.
Her vitals were normal on ambient air. Leukocytosis of 11.9 and
a chronic stable anemia with hemoglobin of 8.2 was noted on her
initial blood count. Her creatinine and blood urea nitrogen were
normal. Blood cultures were negative. Magnetic resonance imaging
(MRI) of the spine (Fig. 1) showed persistent Spondylodiscitis at L3-
4. Therewas persistent enhancement of the adjacent psoas muscles
with associated phlegmon along the epidural space at L3-5 level.
She was immediately re-started on Vancomycin. Surgical Drainage
of the possible abscess was carried out in conjunction with spine
stabilization. Culture of tissue obtained showed MRSA. Oral
rifampin was added soon after the surgery. On the 9th day post
admission patient developed gross hematuria and her renal func-
tion started to deteriorate. Urine studies suggested an intrinsic
renal etiology with moderate proteinuria. The gross hematuria
prevented urine microscopy from revealing casts or ruling their
presence out. This was accompanied by hydronephrosis on
abdominal imaging. Cystoscopy revealed clots in the ureters and
bilateral ureteric bypass stents were inserted. Kidney function
continued to deteriorate and she required hemodialysis. Initial
work up for her hematuria and proteinuria was negative including
negative P-ANCA, C-ANCA. Within 2 days of her cystoscopy she
started to complain of progressive worsening dyspnea associated
with oxygen desaturation. Her HGB further dropped by 2 g. Chest x-
ray (Fig. 2) preformed and showed bilateral interstitial opacities
suggestive of pulmonary edema. Patient continued to worsen
despite repeated daily dialysis and had to be intubated for wors-
ening respiratory distress. Lung protective ventilation was insti-
tuted immediately after intubation. Bronchoscopic alveolar lavage
(BAL) was preformed and conﬁrmed the suspicion of diffuse alve-
olar hemorrhage (DAH) with increasing blood content of the
sequential aliquots from both right middle lobe and lingular seg-
ments. Pulmonary renal syndrome was considered and plasma
exchange therapy (PLEX) with high dose steroids initiated. Vanco-
mycin and rifampin were continued. Workup for pulmonary renalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. MRI lumbar.
Fig. 2. Chest X ray.
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normal. Patient showed dramatic improvement and she was
weaned off the mechanical ventilation after the 4th session of PLEX
(day 7 of mechanical ventilation). Renal biopsy was performed and
showed features of acute tubular necrosis and immune complex
deposits consistent with active staphylococcus infection-associated
glomerulonephritis [11] (Figs. 3 and 4). Unfortunately her course of
stay in the hospital worsened after weaning her steroids down and
patient was admitted once more to intensive care unit (ICU) withFig. 3. Mild mesangial granular standing for C3.worsening hypoxia and she was intubated. Repeat Bronchoscopy
revealed recurrence diffuse alveolar hemorrhage. Steroids were
initiated again with signiﬁcant improvement. She was successfully
extubated in 6 days and was eventually discharged home on oral
steroids. No other immunosuppressive agents were used due to the
infection status of the patient.
3. Discussion
Vasculitides are often serious and even fatal diseases that
require rapid recognition [4]. They are deﬁned by the presence of
inﬂammatory leukocytes in vessel walls with reactive damage to
mural structures. Both loss of vessel integrity leading to bleeding,
and compromise of the lumen may result in downstream tissue
ischemia and necrosis [3]. We can classify vasculitis according to
the involved vessels location, type, size and ANCA positive or
negative vasculitis [5]. Vasculitis may occur as a primary process or
may be secondary to another underlying disease like infection. The
exact pathogenic mechanisms underlying these diseases are
unknown.
The ANCA associated vasculitis (AAV) include three groups of
vasculitides; Microscopic polyangitis (MPA), granulomatosis with
polyangitis (Wegener's)(GPA), and eosinophilic granulomatosis
with polyangitis (Churg-Strauss) (EGPA) [5].
There are many bacterial and viral infections associated with
different types of vasculitis. MRSA associated with microscopic
polyangitis with P-ANCA is reported [2], as well as post MRSA
infection IgA glomerulonephritis [2]. MRSA carriage or infection
has been associated with cases of C-ANCA vasculitis (Wegener
granulomatosis) [12e14]. We have not identiﬁed a case with the
synchronous evolution of MRSA induced glomerulonephritis and
DAH. Our case is unique given the development MRSA induced
vasculitis and Pulmonary-renal syndrome. It makes it more unique
that the occurrence of pulmonary renal syndrome was caused by 2
different mechanisms. In this case, glomerulonephritis represents
post-infectious rather than pauci-immune mediated injury. This is
evident by the mesangial hypercellularity as well as glomerular
complement 3, and IgA deposition along with the classic sub-
epithelial humps as shown in (Figs. 5 and 6) [10]. Although the DAH
was not biopsy proven to be secondary to a vasculitis problem, we
believe this was the case based on the rapid improvement with
plasma exchange and use of steroids. The recurrence of the alveolar
hemorrhagewhile patient was still on antibiotics and after weaning
the steroids makes it more likely that the DAH was inﬂammation
induced. The presence of C-ANCA antibodies and the response to
PLEX and steroids are strong indicators of active vasculitis [7e9].Fig. 4. Glomerulus with mesangial hypercellularity. H&E.
Fig. 5. Segmental granular glomerular IgA.
Fig. 6. Subepithelial humps.
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in the development of ESRD comparing to the conventional treat-
ment with prednisone and cyclophosphamide [6e8]. The Use of
PLEX in AAV associated alveolar hemorrhage and pulmonary renal
syndrome can be life saving [14], Other possible etiologies to the
pulmonary-renal syndrome are possible, but very unlikely in this
case. Drug induced renal injury is a well-known entity. They are
unlikely the cause of the pulmonary renal syndrome based on the
renal biopsy ﬁndings. In addition, none of her medications are
known to induce ANCA vasculitis. The patient did not have anyother infection or known disease or drug exposure that would
explain the alveolar hemorrhage. She is not known to have active
rheumatologic disease and there was no sign of active heart failure
to cause a bland hemorrhage. The lack of volume overload
(repeated dialysis) or ARDS/diffuse alveolar damage evidenced by
the rapid improvement in respiratory parameters make the di-
agnoses of ANCA associated DAH the only available clinical expla-
nation. Our case has signiﬁcant implications. It is the ﬁrst to
describe DAH related to immunologic response to MRSA infection.
It also stresses the fact that multiple diseases can present due to the
same etiology but with different mechanisms. Treatment of infec-
tion alone sometimes is not sufﬁcient. Treating the deranged
immunologic response to chronic infection is as important in
improving patient outcomes. we hope our case will spark the in-
terests of the readers and help spread the knowledge of the mul-
tiple effects of chronic bacterial infections.References
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